A case of hypertrophic cardiomyopathy combined with muscular ventricular septal defect and abnormal origin of right coronary artery.
Autor: | Zheng GM; Department of ultrasound, Renmin Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China., Bai J; Department of ultrasound, Renmin Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China., Tang JM; Institute of clinical medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China., Zhu FC; Department of Forensic Medicine, Hubei University of Medicine, Shiyan, 442000, Hubei, China. 474853596@qq.com., Jing HX; Department of ultrasound, Renmin Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | BMC cardiovascular disorders [BMC Cardiovasc Disord] 2019 Jan 14; Vol. 19 (1), pp. 16. Date of Electronic Publication: 2019 Jan 14. |
DOI: | 10.1186/s12872-018-0997-8 |
Abstrakt: | Background: Hypertrophic cardiomyopathy (HCM) is a myocardial disease. However, the coexistence of HCM with muscular ventricular septal defect (VSD), especially those with both incomplete spontaneous closure and coronary abnormal origin, is relatively rare. Case Presentation: We report herein a unique case of HCM accompanied with incomplete spontaneous closure of muscular VSD and abnormal origin of right coronary artery (RCA) in a 26-year-old man, which was diagnosed by combination of transthoracic 2-dimensional (2D), color Doppler, Contrast-enhanced echocardiography and computed tomography angiography (CTA). Conclusions: To our knowledge, this is the first report that HCM along with the incomplete spontaneous closure of muscular VSD and anomalous RCA arising from left coronary sinus was revealed through combination of transthoracic 2D, color Doppler, Contrast-enhanced echocardiography and CTA. These observations indicated that other associated anomalies in patients with HCM could be easily missed if examined by the single echocardiography. Therefore, HCM-associated congenital abnormalities should be screened by combination of transthoracic 2D, color Doppler, contrast-enhanced echocardiography, and CTA. |
Databáze: | MEDLINE |
Externí odkaz: |